Sektor Monte Rosa Therapeutics, Inc.

Aktien

A3CS44

US61225M1027

GLUE

Biotechnologie

Markt geschlossen - 22:00:00 21.08.2026 % 5 Tage Veränd. 1. Jan.
14.30 USD -3.25% Intraday Chart für Monte Rosa Therapeutics, Inc. -7.74% -8.80%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
-3.25%-7.74%-37.91%-23.98%-8.80%+196.68%+123.79%-61.29% - 1.22 Mrd.
+1.09%+5.26%+9.22%+20.17%+10.12%+4.52%+23.38%-22.79%+213.33% 51.61 Mrd.
-1.07%+2.82%+10.97%+38.20%+162.98%+465.96%+570.70%+705.93% - 44.89 Mrd.
+1.47%+9.79%+25.32%+54.75%+15.27%+35.92%+20.21%+2.14%+241.82% 42.77 Mrd.
+1.44%+7.77%+14.60%+20.70%+23.26%+19.38%+84.65%+37.00%+1’173.27% 42.58 Mrd.
-0.93%-4.33%+11.67%+1.62%+11.56%+16.18%+55.82%-17.64%+149.91% 31.82 Mrd.
+1.32%+7.30%+2.46%+43.43%+10.52%+33.89%+148.53%+246.25%+2’026.58% 17.33 Mrd.
-0.60%+1.93%+0.25%+2.53% - - - - - 16.63 Mrd.
+0.03%+3.41%+10.16%+16.40%+16.73%+6.55%+29.84%-38.78%+95.81% 14.76 Mrd.
+1.28%+5.41%+28.74%+84.15%+47.98%+82.40%+46.13%-30.68%+253.31% 14.09 Mrd.
-1.17%+5.57%+1.12%+47.48%-5.48%-2.05%-31.86%-29.70%+123.88% 13.29 Mrd.
+9.06%+39.52%+57.99%+57.41%+23.10%-9.72% - - - 13.12 Mrd.
-5.74%-2.32%+23.03%+85.04%+68.77%+59.40%+79.43%-40.22% - 12.06 Mrd.
+0.06%-0.11%+0.77%+50.01%+22.97%+26.68%-8.08%-39.72%+171.29% 11.34 Mrd.
+1.60%-0.88%-11.09%-3.87%-15.45%+53.08%+505.95%+254.09%+2’483.76% 11.12 Mrd.
+3.12%+2.49%+16.61%+9.42%+27.55%+670.68%+1’582.06%+26.39% - 10.5 Mrd.
0.00%+0.15%+0.36%+66.03%+78.52%+252.10%+448.88% - - 10.16 Mrd.
+2.41%-0.50%+13.95%+55.58%+76.69%+168.48%+657.58%+211.19%+1’244.25% 9.99 Mrd.
-1.40%+2.05%+8.53%+51.86%+53.96%+171.66%+490.15%+116.60% - 9.96 Mrd.
+1.67%+4.37%+6.93%-20.94%-24.48%+39.94%+50.40%+53.06%+77.22% 9.93 Mrd.
Durchschnitt +0.52%+4.04%+9.68%+32.80%+31.36%+120.62%+270.98%+80.70%+687.87% 19.46 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung +0.62%+4.92%+12.87%+32.87%+38.23%+109.95%+211.66%+115.62%+593.36%
  1. Börse
  2. Aktien
  3. A3CS44 Aktie
  4. Sektor Monte Rosa Therapeutics, Inc.